RecruitingNCT06164795

Sequential Therapies After Osteoanabolic Treatment

Efficacy of Sequential Therapies After Osteoanabolic Treatment in Postmenopausal Women With Severe Osteoporosis: the Sequential Treatment After Romosozumab and Teriparatide/Abaloparatide (START) Study

Sponsor

424 General Military Hospital

Enrollment

150 participants

Start Date

Nov 25, 2023

Study Type

OBSERVATIONAL

Conditions

Osteoporosis, Postmenopausal

Summary

12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics

Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Abaloparatide Injection (80 mcg), a drug called Denosumab, and others for people with osteoporosis, postmenopausal. The study is currently recruiting participants at 8 locations. People eligible for this study include women aged 50 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGZoledronate

intravenous infusion

DRUGDenosumab

subcutaneous injection

DRUGTeriparatide

subcutaneous injection

DRUGRomosozumab

subcutaneous injection

DRUGAbaloparatide Injection (80 mcg)

daily subcutaneous injection

Locations(8)

251 Airforce & VA General Hospital

Athens, Greece

First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens

Athens, Greece

, KAT General Hospital

Athens, Greece

424 General Military Hospital

Thessaloniki, Greece

Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico

Milan, Italy

Campus Bio-Medico University

Roma, Italy

Department of Medicine, Surgery and Neurosciences, University of Siena

Siena, Italy

University-Hospital S. Maria della Misericordia

Udine, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06164795

Related Trials

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

NCT069381521 location

Combined Anabolic Therapy

NCT065581881 location

Mechanisms of Anabolic Osteoporosis Therapy

NCT056889691 location

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

NCT072534931 location

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

NCT072426121 location